Citation 103066

LEE,SF: LIN,JK:. (1997). INHIBITORY EFFECTS OF PHYTOPOLYPHENOLS ON TPA-INDUCED TRANSFROMATION, PKC ACTIVATION, AND C-JUN EXPRESSION IN MOUSE FIBROBLAST CELLS.. 28(2)

Citation Details

Title	INHIBITORY EFFECTS OF PHYTOPOLYPHENOLS ON TPA-INDUCED TRANSFROMATION, PKC ACTIVATION, AND C-JUN EXPRESSION IN MOUSE FIBROBLAST CELLS.
Authors	LEE,SF: LIN,JK:
Year	1997
Volume	28
Issue	2

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
2	GENE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
3	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
4	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
5	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
6	GENE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
7	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
8	FUNGAL STIMULANT	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
9	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
10	GENE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	WEAK ACTIVITY
11	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
12	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
13	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	ACTIVE
14	GENE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	WEAK ACTIVITY
15	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	WEAK ACTIVITY
16	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	ACTIVE
17	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
18	GENE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
19	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
20	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	WEAK ACTIVITY
21	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	ACTIVE
22	GENE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	WEAK ACTIVITY
23	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	WEAK ACTIVITY
24	CELL TRANSFORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	ACTIVE
25	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
26	GENE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	WEAK ACTIVITY
27	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	WEAK ACTIVITY
28	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
29	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
30	GENE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	WEAK ACTIVITY
31	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
32	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
33	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	WEAK ACTIVITY
34	GENE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
35	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
36	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	INACTIVE
37	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	WEAK ACTIVITY
38	GENE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE
39	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE
40	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE
41	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	ACTIVE
42	GENE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	ACTIVE
43	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	INACTIVE
44	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	ACTIVE
45	PROTEIN KINASE C ACTIVATION	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	WEAK ACTIVITY
46	GENE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	WEAK ACTIVITY
47	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	ACTIVE
48	CELL TRANSFORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	ACTIVE

Citation 103066

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1